Cobus Loots, CEO of Pan African Resources, on delivering sector-leading returns for shareholders. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksABAL.L Regulatory News (ABAL)

  • There is currently no data for ABAL

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Issue of Equity

17 Aug 2018 15:40

RNS Number : 2050Y
Imaginatik PLC
17 August 2018
 

17 August 2018

 

Imaginatik PLC

("Imaginatik" or the "Company")

Issue of Equity

 

Imaginatik plc (AIM: IMTK.L), the #1 ranked leader in corporate innovation management according to Forrester Research, today announces that it has issued 1,443,820 new ordinary shares of 0.02p ("Ordinary Shares") in relation to an exercise of warrants and settlement of amounts outstanding to a creditor, Matthew Cooper.

 

950,000 Ordinary Shares have been issued pursuant to an exercise of warrants at an exercise price of 5p per warrant (the "Warrants"). The Warrants were granted to and exercised by Peterhouse Capital Limited pursuant to the fundraising announced by the Company on 5 June 2018. The proceeds are to be used for working capital.

 

In addition, the Company has carried out a debt for equity swap in relation to outstanding salary of £24,691 owed to Matthew Cooper during his time as Chairman of the Company resulting in a further issue of 493,820 Ordinary Shares being issued at 5p per Ordinary Share (the "Transaction").

 

The issue of the Creditor Shares is deemed to be a related party transaction as Matthew Cooper is a substantial shareholder as well as a former director of the Company. The directors consider, having consulted with its nominated adviser, that the terms of the Transaction are fair and reasonable insofar as its shareholders are concerned.

 

Application for Admission

 

Application will be made for 1,443,820 Ordinary Shares to be admitted to trading on AIM. It is expected that admission will take place and trading in the new ordinary shares will commence at 8.00am on 23 August 2018.

 

Total voting rights

 

Following Admission, the Company's enlarged issued share capital will be 34,442,531 Ordinary Shares. The Company does not hold any shares in Treasury. Therefore the total number of Ordinary Shares with voting rights will be 34,442,531. This figure may be used by shareholders in the Company as the denominator for the calculations to determine if they are required to notify their interest in, or a change to their interest in, the Company, under the FCA's Disclosure and Transparency Rules.

 

Further update

 

Further to the Company's announcement on 26 July 2018, the Company confirms that Vin Murria continues to be in discussions to make a controlling equity investment in the Company which is now likely to be at a price of 2.5 pence per Ordinary Share, conditional on the Takeover Panel waiving the obligation for her to make a general offer for the Company under Rule 9 of the Takeover Code.

 

A further announcement will be made at the appropriate time.

 

This announcement contains inside information for the purposes of article 7 of Regulation 596/2014

 

For further information please contact:

 

Imaginatik plc

Tel: 01329 243 243

Shawn Taylor, CFO

 

finnCap Ltd - Nomad and broker

Tel: 020 7220 0500

Jonny Franklin-Adams/Max Bullen-Smith, corporate finance

Camille Gochez, corporate broking

 

Peterhouse Capital Limited - Joint broker

Tel: 020 7220 9797

Duncan Vasey / Lucy Williams

 

Alma PR

Tel: 020 8004 4218

Caroline Forde / Robyn Fisher

 

About Imaginatik

 

Imaginatik is the only innovation solution provider which has combined a proven innovation program with purpose-built idea management software to enable companies to achieve breakthrough and continuous innovation at scale. Imaginatik works with leading global enterprises to build and integrate innovation management skills as a core competency. Customers include ExxonMobil, Altria, Shell, Goodyear, AECOM, Caterpillar, Novartis and Cargill.

 

Imaginatik is a public company traded on the AIM market of the London Stock Exchange (LSE: IMTK.L) with offices in Boston, MA, USA and Fareham, U.K.

 

For more information visit www.imaginatik.com.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
IOEEALPXFDNPEFF
Date   Source Headline
19th Dec 20083:16 pmRNSDirector/PDMR Shareholding
18th Dec 20089:45 amRNSDirector/PDMR Shareholding
17th Dec 20087:00 amRNSShare Option Schemes
1st Dec 20087:00 amRNSDirector's Disclosure Update
19th Nov 200812:39 pmRNSDirectors Dealing
13th Nov 20087:00 amRNSInterim Results
14th Oct 20087:00 amRNSTrading Statement
2nd Oct 20087:00 amRNSContract Win
30th Sep 20084:30 pmRNSTotal Voting Rights
24th Sep 20087:00 amRNSDirector/PDMR Shareholding
15th Sep 20087:00 amRNSContract Win
3rd Sep 20087:00 amRNSIssue of Equity
21st Aug 20087:00 amRNSContract Win
28th Jul 20089:27 amRNSNon-Executive Retirement
10th Jul 200810:20 amRNSResult of AGM
10th Jul 20087:00 amRNSAGM Statement
24th Jun 20087:00 amRNSDirector/PDMR Shareholding
18th Jun 200810:05 amRNSAnnual Report and Accounts
13th Jun 200812:16 pmRNSDirector/PDMR Shareholding
11th Jun 20087:00 amRNSFinal Results
1st Apr 200811:52 amRNSDirector Dealings
31st Mar 20084:30 pmRNSTotal Voting Rights
17th Mar 20082:57 pmRNSShare Subscription - Update
10th Mar 20082:23 pmRNSShare Subscription
10th Mar 20089:30 amRNSHolding(s) in Company
28th Feb 200810:01 amRNSPfizer Update
13th Feb 20089:40 amRNSTrading Statement
22nd Jan 20089:30 amRNSWorld Economic Forum
11th Jan 200810:13 amRNSMajor Contract Wins
30th Nov 20072:41 pmRNSWEF Technology Pioneer
14th Nov 20072:12 pmRNSInterim Results
16th Aug 200711:05 amRNSAgreement With IBM
14th Aug 20074:55 pmRNSAIM Rule 26 Information
27th Jul 200710:46 amRNSAGM Statement
27th Jul 20077:01 amRNSAGM Statement
11th Jul 200712:00 pmBUSGlobal Competition Forces Innovation and Collaboration Acceleration
29th Jun 20073:33 pmRNSAnnual Report and Accounts
13th Jun 200711:50 amRNSResult of EGM
12th Jun 20077:02 amRNSFinal Results
4th Jun 20077:02 amRNSUK & European Contract Wins
1st Jun 200710:29 amRNSNotice of Results
18th May 200710:05 amRNSNotice of EGM
23rd Apr 20072:38 pmBUSImaginatik Wins a Queens Award for Enterprise
23rd Apr 200711:02 amRNSWins A Queens Award
19th Apr 200710:59 amRNSDirector/PDMR Shareholding
21st Mar 20077:04 amRNSSenior Management Appointment
21st Mar 20077:01 amBUSImaginatik Appoints President, Americas and New CMO to Accommodate Growth
16th Mar 200711:45 amRNSTrading Statement
9th Feb 200711:30 amBUSImaginatik Appoints Managing Director in United Kingdom
9th Feb 20077:00 amRNSAppointment of UK MD

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.